Surgical and Oncologic Outcomes of Laparoscopic Versus Open Radical Nephrectomy with Venous Thrombectomy: A Propensity-Matched Retrospective Cohort Study

IF 0.3 Q4 ONCOLOGY International Journal of Surgery-Oncology Pub Date : 2021-08-30 DOI:10.29337/ijsonco.127
Yu Zhang, H. Bi, Ye Yan, Zhuo Liu, Guo-liang Wang, Yimeng Song, J. Dong, Shudong Zhang, Cheng Liu, Lulin Ma
{"title":"Surgical and Oncologic Outcomes of Laparoscopic Versus Open Radical Nephrectomy with Venous Thrombectomy: A Propensity-Matched Retrospective Cohort Study","authors":"Yu Zhang, H. Bi, Ye Yan, Zhuo Liu, Guo-liang Wang, Yimeng Song, J. Dong, Shudong Zhang, Cheng Liu, Lulin Ma","doi":"10.29337/ijsonco.127","DOIUrl":null,"url":null,"abstract":"Background: To compare the surgical and oncologic outcomes between laparoscopic and open radical nephrectomy with venous thrombectomy (LRN-VT, ORN-VT) in patients with renal tumor and venous thrombus. Materials and Methods: We conducted a propensity-matched retrospective cohort study of 302 patients with renal tumor and venous thrombus from January 2014 to January 2021. We compared surgical outcomes and we used the Kalan-Meier method to assess the overall survival (OS), tumor-specific survival (TSS), metastasis-free survival (MFS) and local recurrence-free survival (LRFS). The Pearson chi-square test and Fisher exact test, Wilcoxon rank sum test, Cox proportional hazards regression model and log-rank test were used. Results: After 1:1 matching, 94 patients were identified in each group and baseline characteristics were comparable. The LRN-VT group had less operative time (median 292min vs 326min, P < 0.001), less blood loss (median 500 ml vs 1000 ml, P < 0.001), fewer packed red blood cells transfusion (median 800 ml vs 1200 ml, P < 0.001) and less fresh frozen plasma transfusion (median 400 ml vs 600 ml, P < 0.001). The ORN-VT group had higher complication rate (39.4% vs 21.3%, P = 0.007), higher Clavien grade (P = 0.005) and longer postoperative hospital stay (median 10d vs 8d, P < 0.001). The median time to local recurrence were 36mon after a median follow-up of 31mon in the LRN-VT group and 8mon (IQR 6-15 mon) after a median follow-up of 32mon in the ORN-VT group (P = 0.007). The hazard ratio of LRFS for the LRN-VT group was 0.18 (95% CI 0.05–0.62, P = 0.007). Conclusions: LRN-VT can result in favorable surgical outcomes and a better LRFS compared with ORN-VT. CORRESPONDING AUTHORS: Cheng Liu and LuLin Ma Department of Urology, Peking University Third Hospital, Beijing, People’s Republic of China, 49 North Garden Rd, Haidian District, Beijing 100191, China chengliu@bjmu.edu.cn; malulinpku@163.com","PeriodicalId":42930,"journal":{"name":"International Journal of Surgery-Oncology","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Surgery-Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29337/ijsonco.127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To compare the surgical and oncologic outcomes between laparoscopic and open radical nephrectomy with venous thrombectomy (LRN-VT, ORN-VT) in patients with renal tumor and venous thrombus. Materials and Methods: We conducted a propensity-matched retrospective cohort study of 302 patients with renal tumor and venous thrombus from January 2014 to January 2021. We compared surgical outcomes and we used the Kalan-Meier method to assess the overall survival (OS), tumor-specific survival (TSS), metastasis-free survival (MFS) and local recurrence-free survival (LRFS). The Pearson chi-square test and Fisher exact test, Wilcoxon rank sum test, Cox proportional hazards regression model and log-rank test were used. Results: After 1:1 matching, 94 patients were identified in each group and baseline characteristics were comparable. The LRN-VT group had less operative time (median 292min vs 326min, P < 0.001), less blood loss (median 500 ml vs 1000 ml, P < 0.001), fewer packed red blood cells transfusion (median 800 ml vs 1200 ml, P < 0.001) and less fresh frozen plasma transfusion (median 400 ml vs 600 ml, P < 0.001). The ORN-VT group had higher complication rate (39.4% vs 21.3%, P = 0.007), higher Clavien grade (P = 0.005) and longer postoperative hospital stay (median 10d vs 8d, P < 0.001). The median time to local recurrence were 36mon after a median follow-up of 31mon in the LRN-VT group and 8mon (IQR 6-15 mon) after a median follow-up of 32mon in the ORN-VT group (P = 0.007). The hazard ratio of LRFS for the LRN-VT group was 0.18 (95% CI 0.05–0.62, P = 0.007). Conclusions: LRN-VT can result in favorable surgical outcomes and a better LRFS compared with ORN-VT. CORRESPONDING AUTHORS: Cheng Liu and LuLin Ma Department of Urology, Peking University Third Hospital, Beijing, People’s Republic of China, 49 North Garden Rd, Haidian District, Beijing 100191, China chengliu@bjmu.edu.cn; malulinpku@163.com
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
腹腔镜与开放式根治性肾切除术合并静脉血栓切除术的手术和肿瘤预后:一项倾向匹配的回顾性队列研究
背景:比较腹腔镜和开放式根治性肾切除术合并静脉血栓切除术(LRN-VT, ORN-VT)对肾肿瘤和静脉血栓患者的手术和肿瘤预后。材料与方法:2014年1月至2021年1月,我们对302例肾肿瘤和静脉血栓患者进行了倾向匹配的回顾性队列研究。我们比较了手术结果,并使用Kalan-Meier法评估总生存期(OS)、肿瘤特异性生存期(TSS)、无转移生存期(MFS)和局部无复发生存期(LRFS)。采用Pearson卡方检验、Fisher精确检验、Wilcoxon秩和检验、Cox比例风险回归模型和log-rank检验。结果:经1:1匹配后,每组确定94例患者,基线特征具有可比性。LRN-VT组手术时间更短(中位292min vs 326min, P < 0.001),出血量更少(中位500 ml vs 1000 ml, P < 0.001),填充红细胞输注更少(中位800 ml vs 1200 ml, P < 0.001),新鲜冷冻血浆输注更少(中位400 ml vs 600 ml, P < 0.001)。ORN-VT组并发症发生率较高(39.4% vs 21.3%, P = 0.007), Clavien分级较高(P = 0.005),术后住院时间较长(中位10d vs 8d, P < 0.001)。LRN-VT组中位随访31个月后的中位局部复发时间为36个月,ORN-VT组中位随访32个月后的中位局部复发时间为8个月(IQR 6 ~ 15个月)(P = 0.007)。LRN-VT组LRFS的风险比为0.18 (95% CI 0.05 ~ 0.62, P = 0.007)。结论:与ORN-VT相比,LRN-VT可获得良好的手术效果和更好的LRFS。通讯作者:刘成、马鲁林中华人民共和国北京大学第三医院泌尿外科,北京市海淀区北花园路49号,中国北京,100191 chengliu@bjmu.edu.cn;malulinpku@163.com
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
8
期刊最新文献
Retifanlimab: a breakthrough for the management of Merkel cell carcinoma Outcomes of the distal rectal cancer treatment depending on the type of sphincter-sparing surgery Mucinous adenocarcinoma of the urachus: a practical overview of a broad differential diagnosis: case report Spatial and temporal epidemiological analysis on the mortality rate of female breast cancer in Suzhou, China: 2006–2020 Role of Denosumab in the Management of Giant Cell Tumor, a Cross Sectional Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1